Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

RNF113B Inhibitors

RNF113B is a member of the ring finger protein family of E3 ubiquitin ligases, which are characterized by the presence of a zinc-finger domain that binds two zinc ions. The defining feature of RNF proteins is their role in mediating the transfer of ubiquitin to specific substrate proteins, a process that typically tags these substrates for proteasomal degradation but can also alter their activity, location, or interactions. The ubiquitination process is crucial for numerous cellular processes, including cell cycle regulation, DNA repair, and signal transduction.

The RNF113B gene encodes the RNF113B protein, which exhibits a distinctive pattern of expression and biological function. As an E3 ubiquitin ligase, RNF113B is involved in the post-translational modification of proteins through the ubiquitin-proteasome system. This system maintains cellular homeostasis by controlling the degradation of misfolded, damaged, or unnecessary proteins.The specific substrates and molecular mechanisms of action for RNF113B are not as well characterized as those of some other members of the RNF family. However, like other E3 ligases, RNF113B is believed to participate in the intricate regulation of cellular processes through its enzymatic activity. The ubiquitination of proteins by RNF113B could impact various cellular pathways, such as the stress response, DNA damage repair, or transcriptional regulation, by affecting the stability and function of key regulatory proteins.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

A proteasome inhibitor that could impact the degradation of ubiquitinated proteins.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Another proteasome inhibitor, used in cancer therapy, might influence RNF113B-related pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor, can influence various signaling pathways, potentially affecting RNF113B.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, which might indirectly affect proteins involved in cell growth and survival.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

An HDAC inhibitor, which could affect gene expression, potentially influencing RNF113B.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor, potentially altering gene expression profiles.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An inhibitor of MEK, which could affect signaling pathways relevant to RNF113B function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, potentially influencing pathways associated with RNF113B.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A PI3K inhibitor, similar to LY294002, could affect signaling pathways impacting RNF113B.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$56.00
$212.00
$764.00
24
(1)

Disrupts the MDM2-p53 interaction, potentially influencing pathways associated with RNF113B.